Codexis, Inc. (CDXS)
NASDAQ: CDXS · Real-Time Price · USD
3.490
-0.010 (-0.29%)
At close: Nov 4, 2024, 4:00 PM
3.500
+0.010 (0.29%)
After-hours: Nov 4, 2024, 5:26 PM EST
Codexis Employees
Codexis had 174 employees as of December 31, 2023. The number of employees decreased by 74 or -29.84% compared to the previous year.
Employees
174
Change (1Y)
-74
Growth (1Y)
-29.84%
Revenue / Employee
$370,379
Profits / Employee
-$356,851
Market Cap
247.54M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Accolade | 2,400 |
Poseida Therapeutics | 330 |
Amarin Corporation | 275 |
Editas Medicine | 265 |
Omeros | 198 |
TScan Therapeutics | 154 |
Rigel Pharmaceuticals | 147 |
Nektar Therapeutics | 137 |
CDXS News
- 3 days ago - Codexis, Inc. (CDXS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 11 days ago - Codexis Announces Three siRNA Manufacturing Data Presentations at TIDES Europe Annual Meeting - GlobeNewsWire
- 21 days ago - Codexis Announces New Employment Inducement Grants - GlobeNewsWire
- 25 days ago - Codexis to Report Third Quarter 2024 Financial Results on October 31 - GlobeNewsWire
- 4 weeks ago - Codexis Increases Cash Reserves and Enhances Management Team to Fuel Growth of Company - GlobeNewsWire
- 4 weeks ago - Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences - GlobeNewsWire
- 2 months ago - Codexis to Participate in Upcoming Healthcare Conferences - GlobeNewsWire
- 2 months ago - Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual Meeting - GlobeNewsWire